Search Results for gluconeogenesis - 165 interactions found in 85 entries.

Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
315
1247 Insulin decreases_activity of gluconeogenesis
10949029 Diabetes mellitus, type II
Insulin resistance
459
2036 STK11 affects_activity of gluconeogenesis
12749 CRTC2 affects_activity of gluconeogenesis
12753 Metformin decreases_activity of gluconeogenesis in liver
16308421 Diabetes mellitus, type II
Peutz-Jeghers syndrome
Insulin resistance
462
2089 AMPK affects_activity of gluconeogenesis
15855317 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
468
2190 PCK1 affects_activity of gluconeogenesis
2194 FBP affects_activity of gluconeogenesis
15561958 Diabetes mellitus, type II
Insulin resistance
519
2599 AMPK affects_activity of gluconeogenesis
18719600 Diabetes mellitus, type II
Peutz-Jeghers syndrome
Wolff-Parkinson-White syndrome
Cardiomyopathy, hypertrophic
Insulin resistance
Metabolic syndrome
549
2829 AMPK decreases_activity of gluconeogenesis
20028864 Breast cancer
Colorectal cancer
Diabetes mellitus, type II
Obesity
Insulin resistance
Metabolic syndrome
589
3123 RETN affects_activity of gluconeogenesis
14976316 Diabetes mellitus, type II
Obesity
Insulin resistance
595
3150 AMPK decreases_activity of gluconeogenesis in liver
19665995 Diabetes mellitus, type II
Insulin resistance
714
4044 Insulin decreases_activity of gluconeogenesis
4045 G6PC increases_activity of gluconeogenesis
4046 PCK1 increases_activity of gluconeogenesis
13068 fasting increases_activity of gluconeogenesis via increased nuclear level of FOXO1
13071 feeding decreases_activity of gluconeogenesis via increased cytoplasmic level of FOXO1
13072 FOXO1 increases_activity of gluconeogenesis in liver
18927507 Diabetes mellitus, type II
Abetalipoproteinemia
Insulin resistance
Fatty liver disease, nonalcoholic
Cardiovascular disease
824
4841 PPARGC1A affects_activity of gluconeogenesis in liver
4844 PPARGC1A increases_activity of gluconeogenesis in liver; if PPARGC1A is overexpressed
4858 G6PC increases_activity of gluconeogenesis in liver
4859 PCK1 increases_activity of gluconeogenesis in liver
4868 KAT2A decreases_activity of gluconeogenesis in liver
4907 SIRT1 decreases_activity of gluconeogenesis
19770177 Diabetes mellitus, type II
Obesity
Insulin resistance
906
5486 SIRT1 affects_activity of gluconeogenesis if SIRT1 is knocked down in liver and adipose tissue of diabetic rats
19549853 Diabetes mellitus, type II
Insulin resistance
918
5569 prolonged fasting decreases_activity of gluconeogenesis in liver
5576 CRTC2 increases_activity of gluconeogenesis in liver; after short-term fasting
5577 FOXO1 increases_activity of gluconeogenesis in liver; after long-term fasting when CRTC2 is degraded
18849969 Diabetes mellitus, type II
Insulin resistance
1,092
6926 Insulin decreases_activity of gluconeogenesis in liver
6928 Insulin resistance increases_activity of gluconeogenesis in liver
6967 insulin receptor signaling pathway via phosphatidylinositol 3-kinase decreases_activity of gluconeogenesis
18053812 Diabetes mellitus, type II
Obesity
Insulin resistance
1,311
8988 Sodium phenylbutyrate decreases_activity of gluconeogenesis in liver
8989 Tauroursodeoxycholic acid decreases_activity of gluconeogenesis in liver
16931765 Diabetes mellitus, type II
Insulin resistance
1,450
10217 IL6 decreases_activity of gluconeogenesis if IL6 is overexpressed in skeletal muscle
18437347 Diabetes mellitus, type II
Insulin resistance
1,453
10259 SPP1 affects_activity of gluconeogenesis in liver
20107108 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
1,663
12230 IL6 decreases_activity of gluconeogenesis in liver
20816090 Diabetes mellitus, type II
Obesity
Insulin resistance
2,266
19342 SPP1 affects_activity of gluconeogenesis in liver
21562757 Diabetes mellitus, type II
Obesity
Insulin resistance
Fatty liver disease, nonalcoholic
2,403
21406 Diabetes mellitus, type II increases_activity of gluconeogenesis in liver
1401068 Diabetes mellitus, type II
Insulin resistance
2,609
24920 CRY1 decreases_activity of gluconeogenesis by blocking glucagon-mediated increases in intracellular cAMP concentrations and in the protein kinase A-mediated phosphorylation of Creb
20852621 Diabetes mellitus, type II
Insulin resistance
2,696
25232 DUSP9 decreases_activity of gluconeogenesis
18296638 Diabetes mellitus, type II
Insulin resistance
Fatty liver disease, nonalcoholic
2,831
26130 Diabetes mellitus, type II increases_activity of gluconeogenesis in liver
26131 Metformin decreases_activity of gluconeogenesis in liver
26132 gluconeogenesis increases_activity of hepatic glucose production in liver
11118008 Diabetes mellitus, type II
Insulin resistance
2,868
26442 Metformin decreases_activity of gluconeogenesis in liver; independent of AMPK catalytic chains and independent of STK11 (LKB1)
20577053 Diabetes mellitus, type II
Insulin resistance
2,977
27112 NEUROD1 NOT affects_activity of gluconeogenesis
27114 G6PC increases_activity of gluconeogenesis
20374962 Diabetes mellitus, type II
Insulin resistance
MODY, type VI
3,019
27690 Cortisol increases_activity of gluconeogenesis in liver
21898408 Diabetes mellitus, type II
Insulin resistance
Major depressive disorder
3,044
27980 Cortisol increases_activity of gluconeogenesis in liver
11724664 Diabetes mellitus, type II
Insulin resistance
Major depressive disorder
3,312
30411 HSD11B1 affects_activity of gluconeogenesis
18029262 Diabetes mellitus, type II
Insulin resistance
3,340
30698 Carbenoxolone NOT affects_activity of gluconeogenesis
12519867 Diabetes mellitus, type II
Obesity
Insulin resistance
3,357
30803 Cortisol increases_activity of gluconeogenesis
20086312 Diabetes mellitus, type II
Insulin resistance
Cushing syndrome
3,388
31850 carnitine deficiency increases_activity of gluconeogenesis in liver
22134503 Diabetes mellitus, type II
Carnitine deficiency, systemic primary
Insulin resistance
Status epilepticus
Cardiovascular disease
-->